...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Vaccine >Domestic influenza vaccine production in Mexico: A state-owned and a multinational company working together for public health
【24h】

Domestic influenza vaccine production in Mexico: A state-owned and a multinational company working together for public health

机译：墨西哥生产国内流感疫苗：一家致力于公共卫生的国有公司和一家跨国公司

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The Mexican Government developed a plan in 2004 for pandemic influenza preparedness that included local production of influenza vaccine. To achieve this, an agreement was concluded between Birmex - a state-owned vaccine manufacturer - and sanofi pasteur, a leading developer of vaccine technology. Under this agreement, sanofi pasteur will establish a facility in Mexico to produce antigen for up to 30 million doses of egg-based seasonal vaccine per year, and Birmex will build a facility to formulate, fill and package the inactivated split-virion influenza vaccine. As at November 2010, the sanofi pasteur facility has been completed and the Birmex plant is under construction. Most of the critical equipment has been purchased and is in the process of validation. In addition to intensive support from sanofi pasteur for the transfer of the technology, the project is supported by the Mexican Ministry of Health, complemented by Birmex's own budget and grants from the WHO developing country influenza technology transfer project
机译：墨西哥政府于2004年制定了大流行性流感防范计划，其中包括本地生产流感疫苗。为了实现这一目标，国有疫苗生产商Birmex与疫苗技术的领先开发商sanofi pasteur达成了一项协议。根据该协议，赛诺菲巴斯德将在墨西哥建立一个生产抗原的设施，每年可生产多达3000万剂蛋基季节性疫苗的抗原，Birmex将建造一个设施以配制，填充和包装灭活的分裂病毒流感疫苗。截至2010年11月，赛诺菲巴斯德工厂已经完成，Birmex工厂正在建设中。大多数关键设备已经购买，并且正在验证中。除了赛诺菲巴斯德为该技术转让提供的大力支持外，该项目还得到了墨西哥卫生部的支持，由Birmex自己的预算和世卫组织发展中国家流感技术转让项目提供的赠款作为补充

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号